Interventions to reduce hypercoagulability in old SIV-infected nhps

Active Project Grant Awarded Last action

Award ID
R01HL123096
Recipient
Awarding agency
Obligated
$6,838,131

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 95% complete
Originally
Place of performance
Pittsburgh, PA 15213, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $793,137
Amendment Impact of netosis on SIV pathogenesis and response to treatment - antiretroviral therapy (art) has dramatically changed the landscape of chronic HIV infection… $793,137
Amendment $781,337
Amendment Impact of netosis on SIV pathogenesis and response to treatment - description (provided by applicant): a prothrombotic status is characteristic to HIV… $781,335
Amendment Interventions to reduce hypercoagulability in old SIV-infected nhps - description (provided by applicant): a prothrombotic status is characteristic to HIV… -$3,397
Amendment $0
Amendment $708,651
Amendment $769,909
Amendment $721,632
Amendment $738,695
Original award $753,695
Show all 12

Subawards

Subrecipient Amount Awarded
University Of Louisiana At Lafayette Impact of NETosis on SIV Pathogenesis and Response to Treatment $196,500
The Research Foundation For The State University Of New York VZV vaccine attenuation and the DNA damage response $132,700

Quick answers

Who received award R01HL123096?

R01HL123096 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Heart Lung and Blood Institute (National Institutes of Health) on July 10, 2015.

How much is award R01HL123096 worth?

$6,838,131 has been obligated on R01HL123096.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login